Reyon Pharmaceutical Co Ltd (102460) — Net Asset Quality Index
Reyon Pharmaceutical Co Ltd (102460) has a Net Asset Quality Index of 49.3% as of September 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of ₩473.11 Billion minus total liabilities of ₩239.99 Billion yields net assets of ₩233.12 Billion. A higher index indicates a stronger, lower-leverage balance sheet. Check asset resilience ratio of Reyon Pharmaceutical Co Ltd to evaluate the company's liquid asset resilience ratio.
Quality Index
Net Assets
Total Assets
Total Liabilities
Reyon Pharmaceutical Co Ltd Net Asset Quality Index Over Time (2008–2024)
This chart shows how Reyon Pharmaceutical Co Ltd's Net Asset Quality Index has evolved across 13 annual periods from 2008 to 2024. As of September 2025, the index stands at 49.3%, representing net assets of ₩233.12 Billion against total assets of ₩473.11 Billion KRW. See Reyon Pharmaceutical Co Ltd (102460) liquidity to equity ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Net Asset Quality Index for Reyon Pharmaceutical Co Ltd (2008–2024)
The table below presents the year-by-year Net Asset Quality Index for Reyon Pharmaceutical Co Ltd from 2008 to 2024, covering 13 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For market capitalisation and the full company profile, see Reyon Pharmaceutical Co Ltd (102460) total market value.
| Year | Quality Index | Net Assets (KRW) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 50.0% | ₩249.94 Billion | ₩499.99 Billion | ₩250.05 Billion | ▲ +0.2 pp |
| 2023 | 49.7% | ₩248.62 Billion | ₩499.78 Billion | ₩251.15 Billion | ▼ -1.4 pp |
| 2022 | 51.1% | ₩247.77 Billion | ₩484.69 Billion | ₩236.93 Billion | ▼ -0.2 pp |
| 2021 | 51.3% | ₩245.24 Billion | ₩477.98 Billion | ₩232.74 Billion | ▼ -21.1 pp |
| 2020 | 72.4% | ₩230.09 Billion | ₩317.61 Billion | ₩87.52 Billion | ▼ -8.5 pp |
| 2019 | 81.0% | ₩222.29 Billion | ₩274.48 Billion | ₩52.19 Billion | ▲ +6.6 pp |
| 2018 | 74.3% | ₩225.39 Billion | ₩303.17 Billion | ₩77.77 Billion | ▼ -1.2 pp |
| 2017 | 75.5% | ₩219.66 Billion | ₩290.84 Billion | ₩71.18 Billion | ▼ -9.9 pp |
| 2016 | 85.5% | ₩179.10 Billion | ₩209.54 Billion | ₩30.44 Billion | ▲ +5.0 pp |
| 2012 | 80.5% | ₩126.36 Billion | ₩156.92 Billion | ₩30.57 Billion | ▲ +1.9 pp |
| 2011 | 78.6% | ₩105.47 Billion | ₩134.20 Billion | ₩28.73 Billion | ▲ +5.6 pp |
| 2009 | 73.0% | ₩59.76 Billion | ₩81.91 Billion | ₩22.15 Billion | ▲ +7.6 pp |
| 2008 | 65.3% | ₩42.63 Billion | ₩65.27 Billion | ₩22.64 Billion | — |